アメリカの体外診断（IVD）市場：免疫測定法、臨床化学、分子診断、微生物...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for The Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 29)
4.1 Growth Potential of The U.S. in Vitro Diagnostics Market
4.2 U.S. in Vitro Diagnostics Market, By End User (2014)
4.3 U.S. in Vitro Diagnostics Market, Regional Mix

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Technology
5.2.3 By Application
5.2.4 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rapid Growth in Geriatric Population and Increasing Incidence of Chronic Diseases in The U.S.
5.3.1.2 Increasing Adoption of Point-Of-Care (POC) Testing
5.3.1.3 Growing Awareness on Personalized Medicine
5.3.1.4 Rise in Reagent Rental Agreements
5.3.1.5 Implementation of The Affordable Care Act (ACA)
5.3.1.6 Increasing Adoption of Automated Instruments and Automation in Laboratories
5.3.2 Restraints
5.3.2.1 Unfavorable Reimbursement Scenario
5.3.2.2 Rising Healthcare Costs and Low Budgets
5.3.3 Opportunities
5.3.3.1 Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.3.4 Challenges
5.3.4.1 Stringent Regulatory Framework

6 U.S. in Vitro Diagnostics Market, By Product & Service (Page No. – 43)
6.1 Introduction
6.2 Reagents
6.3 Instruments
6.3.1 Fully Automated Instruments
6.3.2 Semi-Automated Instruments
6.3.3 Others
6.4 Data Management Software
6.5 Services

7 U.S. in Vitro Diagnostics Market, By Technology (Page No. – 52)
7.1 Introduction
7.2 Clinical Chemistry
7.3 Immunochemistry/Immunoassays
7.4 Microbiology
7.5 Molecular Diagnostics (MDX)
7.6 Hematology
7.7 Coagulation/Hemostasis
7.8 Other IVD Technologies

8 U.S. in Vitro Diagnostics Market, By Application (Page No. – 61)
8.1 Introduction
8.2 Infectious Diseases
8.3 Diabetes
8.4 Oncology/Cancer
8.5 Cardiovascular Disorders
8.6 Endocrine Disorders
8.7 Autoimmune Diseases
8.8 Bone & Mineral-Related Diseases
8.9 Pulmonary Diseases
8.10 Other Applications

9 U.S. in Vitro Diagnostics Market, By End User (Page No. – 74)
9.1 Introduction
9.2 Hospital Laboratories
9.3 Clinical/Independent Laboratories
9.3.1 Large Laboratories/Reference Laboratories
9.3.2 Medium-Sized Laboratories
9.3.3 Small Laboratories
9.4 Other End Users

10 Competitive Landscape (Page No. – 83)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches
10.3.2 Collaborations, Agreements, & Partnerships
10.3.3 Approvals
10.3.4 Mergers & Acquisitions
10.3.5 Others

11 Company Profiles (Page No. – 92)
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Abbott Laboratories, Inc.
11.2 Danaher Corporation
11.3 Johnson and Johnson
11.4 Roche Diagnostics
11.5 Siemens Healthcare
11.6 Becton, Dickinson and Company
11.7 Biom¨¦rieux
11.8 Bio-Rad Laboratories, Inc.
11.9 Sysmex Corporation
11.10 Thermo Fisher Scientific, Inc.
11.11 Qiagen N.V.

12 Appendix (Page No. – 149)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets¡¯ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports